Antidepressant-Like Effects of LPM580153, a Novel Potent Triple Reuptake Inhibitor

Scientific Reports - United Kingdom
doi 10.1038/srep24233
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

The Novel Trisubstituted Pyran Derivative D-142 Has Triple Monoamine Reuptake Inhibitory Activity and Exerts Potent Antidepressant-Like Activity in Rodents

European Journal of Pharmacology
Pharmacology
2011English

Evaluation of the Analgesic Effects of Ammoxetine, a Novel Potent Serotonin and Norepinephrine Reuptake Inhibitor

Acta Pharmacologica Sinica
MedicinePharmacology
2016English

LPM580098, a Novel Triple Reuptake Inhibitor of Serotonin, Noradrenaline, and Dopamine, Attenuates Neuropathic Pain

Frontiers in Pharmacology
Pharmacology
2019English

N-Desalkylquetiapine, a Potent Norepinephrine Reuptake Inhibitor and Partial 5-Ht1a Agonist, as a Putative Mediator of Quetiapine's Antidepressant Activity

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2007English

A New Class of Antidepressant Drugs in the Treatment of Psychiatric Disorders: The Triple Reuptake Inhibitors

2011English

A Novel Histone Deacetylase Inhibitor, CKD5, Has Potent Anti-Cancer Effects in Glioblastoma

Oncotarget
Oncology
2016English

Comparison of the Antidepressant-Like Effects of Estradiol and That of Selective Serotonin Reuptake Inhibitors in Middle-Aged Ovariectomized Rats

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2016English

Anxiolytic and Antidepressant-Like Activities of the Novel and Potent Non-Imidazole Histamine H3 Receptor Antagonist ST-1283

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2014English

Antidepressant-Like Effects of Substances With Cerebroprotective Activity

Biological Markers and Guided Therapy
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy